Bringing into focus the central domains C3-C6 of myosin binding protein C

Bringing into focus the central domains C3-C6 of myosin binding protein C

Myosin binding protein C (MyBPC) is a multi-domain protein with each region having a distinct functional role in muscle contraction. The central domains of MyBPC have often been overlooked due to their unclear roles. However, recent research shows promise in understanding their potential structural...

Full description

Bibliographic Details
Main Authors:	Chang Yoon Doh, Alexandra V. Schmidt, Krishna Chinthalapudi, Julian E. Stelzer
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Physiology
Subjects:	myosin binding protein C central domains hypertrophic cardiomyopathy (HCM) muscle regulation protein dynamics and conformation protein interactions
Online Access:	https://www.frontiersin.org/articles/10.3389/fphys.2024.1370539/full

Similar Items

Increased Postnatal Cardiac Hyperplasia Precedes Cardiomyocyte Hypertrophy in a Model of Hypertrophic Cardiomyopathy
by: Emily T. Farrell, et al.
Published: (2017-06-01)

Transcriptome Analysis of Cardiac Hypertrophic Growth in MYBPC3-Null Mice Suggests Early Responders in Hypertrophic Remodeling
by: Emily Farrell, et al.
Published: (2018-10-01)

Cardiac myosin binding protein C, adrenergic stimulation and cardiac contractility
by: Amsha Ramburan, et al.
Published: (2017-04-01)

Echocardiography and MALDI-TOF Identification of Myosin-Binding Protein C3 A74T Gene Mutations Involved Healthy and Mutated Bengal Cats
by: Kanokwan Demeekul, et al.
Published: (2022-07-01)

Severe apical hypertrophic cardiomyopathy with Ser 236 Gly mutation in MYBPC3: A three-year follow-up investigation
by: XueJiang Cen, et al.
Published: (2017-09-01)

Hypertrophic cardiomyopathy mutations in the pliant and light chain-binding regions of the lever arm of human β-cardiac myosin have divergent effects on myosin function
by: Makenna M Morck, et al.
Published: (2022-06-01)

Cardiac myosin binding protein-C phosphorylation modulates myofilament length-dependent activation
by: Ranganath eMamidi, et al.
Published: (2016-02-01)

Correlation between myocardial myosin-binding protein C, hypertension with left ventricular enlargement, and dilated cardiomyopathy
by: Ya-Li Sun, et al.
Published: (2019-01-01)

Basic science methods for the characterization of variants of uncertain significance in hypertrophic cardiomyopathy
by: Chang Yoon Doh, et al.
Published: (2023-08-01)

Investigation of Mutations in Exons 15 and 18 of MYBPC3 Gene in Hypertrophic Cardiomyopathy Patients
by: Behnaz Sadat Abedi, et al.
Published: (2015-08-01)

The levels of certain circulating microRNAs in hypertrophic cardiomyopathy are associated with echocardiographic parameters
by: Maria V. Pisklova, et al.
Published: (2023-05-01)

Safety and efficacy of mavacamten for treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomized clinical trials
by: Mehrdad Rabiee Rad, et al.
Published: (2023-01-01)

Different Phenotypes in Monozygotic Twins, Carriers of the Same Pathogenic Variant for Hypertrophic Cardiomyopathy
by: Manuel Rodríguez Junquera, et al.
Published: (2022-08-01)

Transcriptome Profile Identifies Actin as an Essential Regulator of Cardiac Myosin Binding Protein C3 Hypertrophic Cardiomyopathy in a Zebrafish Model
by: Sahar Isa Da’as, et al.
Published: (2022-08-01)

Reference values and biological determinants for cardiac myosin-binding protein C concentrations assessed with an enzyme-linked immunosorbent assay
by: Kloska Sylwester M., et al.
Published: (2023-01-01)

Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy
by: Niccolò Maurizi, et al.
Published: (2023-04-01)

Transcriptional regulation of cardiac genes balance pro- and anti-hypertrophic mechanisms in hypertrophic cardiomyopathy
by: Nina Gennebäck, et al.
Published: (2012-06-01)

Prospects for remodeling the hypertrophic heart with myosin modulators
by: Lorenzo R. Sewanan, et al.
Published: (2022-10-01)

Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions
by: Dong T, et al.
Published: (2023-04-01)

A New Leu714Arg Variant in the Converter Domain of MYH7 is Associated with a Severe Form of Familial Hypertrophic Cardiomyopathy
by: Maria V. Golubenko, et al.
Published: (2024-02-01)

From Genetic Mutations to Molecular Basis of Heart Failure Treatment: An Overview of the Mechanism and Implication of the Novel Modulators for Cardiac Myosin
by: Yu-Jen Chen, et al.
Published: (2021-06-01)

DIAGNOSTICAL EXPLORATION ON THE DISEASE PRESENTED AS ACUTE CORONARY SYNDROME, AT THE AGE OF GENETICS. CLINICAL CASE
by: N. S. Krylova, et al.
Published: (2016-10-01)

Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian Descendants
by: Jessica Kraker, et al.
Published: (2016-10-01)

Case Report: Novel LIM domain-binding protein 3 (LDB3) mutations associated with hypertrophic cardiomyopathy family
by: Junmin Zheng, et al.
Published: (2022-11-01)

Cardiac Myosin Inhibitors as a Novel Treatment Option for Obstructive Hypertrophic Cardiomyopathy: Addressing the Core of the Matter
by: Ahmad Masri, et al.
Published: (2022-05-01)

Biomechanical response of ultrathin slices of hypertrophic cardiomyopathy tissue to myosin modulator mavacamten
by: Jorik H. Amesz, et al.
Published: (2024-01-01)

Clinical Application of the HCM-AF Risk Score in the Prediction of Clinical Outcomes of Polish Patients with Hypertrophic Cardiomyopathy
by: Maria Stec, et al.
Published: (2023-07-01)

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
by: Marilena Melas, et al.
Published: (2022-12-01)

Clinical Trials in Hypertrophic Cardiomyopathy Therapy: A Comprehensive Analysis of Trials Registered in Global Clinical Databases
by: Zhang H, et al.
Published: (2023-06-01)

Analysis of organelle targeting by DIL domains of the Arabidopsis myosin XI family
by: Amirali eSattarzadeh, et al.
Published: (2011-11-01)

Familial dilated cardiomyopathy associated with congenital defects in the setting of a novel VCL mutation (Lys815Arg) in conjunction with a known MYPBC3 variant
by: Quinn S. Wells, et al.
Published: (2011-08-01)

Myosin Transducer Inter-Strand Communication Is Critical for Normal ATPase Activity and Myofibril Structure
by: William A. Kronert, et al.
Published: (2022-07-01)

To lie or not to lie: Super-relaxing with myosins
by: Suman Nag, et al.
Published: (2021-02-01)

The Central Role of the F-Actin Surface in Myosin Force Generation
by: Matthew H. Doran, et al.
Published: (2021-11-01)

Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy
by: Chiara Foglieni, et al.
Published: (2022-09-01)

Functional Characterization of Cardiac Actin Mutants Causing Hypertrophic (p.A295S) and Dilated Cardiomyopathy (p.R312H and p.E361G)
by: Roua Hassoun, et al.
Published: (2022-04-01)

Recent Findings Related to Cardiomyopathy and Genetics
by: Takanobu Yamada, et al.
Published: (2021-11-01)

Cardiac myosin super relaxation (SRX): a perspective on fundamental biology, human disease and therapeutics
by: Manuel Schmid, et al.
Published: (2021-02-01)

Allele-specific dysregulation of lipid and energy metabolism in early-stage hypertrophic cardiomyopathy
by: Arpana Vaniya, et al.
Published: (2024-06-01)

A MYH7 variant in a five-generation-family with hypertrophic cardiomyopathy
by: Magda Franke, et al.
Published: (2024-02-01)